Royce & Associates’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-8,365
| Closed | -$489K | – | 1269 |
|
|
2017
Q4 | $489K | Sell |
8,365
-41,232
| -83% | -$2.41M | ﹤0.01% | 1043 |
|
|
2017
Q3 | $3.35M | Sell |
49,597
-19,739
| -28% | -$1.33M | 0.02% | 702 |
|
|
2017
Q2 | $4.74M | Hold |
69,336
| – | – | 0.03% | 605 |
|
|
2017
Q1 | $4.6M | Hold |
69,336
| – | – | 0.03% | 603 |
|
|
2016
Q4 | $4.34M | Buy |
69,336
+2,830
| +4% | +$177K | 0.03% | 623 |
|
|
2016
Q3 | $5.04M | Buy |
66,506
+27,937
| +72% | +$2.12M | 0.03% | 591 |
|
|
2016
Q2 | $1.99M | Sell |
38,569
-10,805
| -22% | -$558K | 0.01% | 809 |
|
|
2016
Q1 | $8.52M | Buy |
49,374
+1,126
| +2% | +$194K | 0.05% | 440 |
|
|
2015
Q4 | $10.6M | Sell |
48,248
-11,642
| -19% | -$2.56M | 0.06% | 391 |
|
|
2015
Q3 | $12M | Buy |
59,890
+44,176
| +281% | +$8.88M | 0.06% | 392 |
|
|
2015
Q2 | $2.29M | Buy |
15,714
+4,412
| +39% | +$644K | 0.01% | 912 |
|
|
2015
Q1 | $1.33M | Buy |
11,302
+167
| +1% | +$19.6K | 0.01% | 997 |
|
|
2014
Q4 | $996K | Buy |
+11,135
| New | +$996K | ﹤0.01% | 1074 |
|